Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage?

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Liu, Shuai nan ^a   Liu, Quan ^a   Li, Lin yi ^a   Huan, Yi ^a   Sun, Su juan ^a   Shen, Zhu fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; FENOFIBRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; GLUTAMATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; NEWBORN; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; DRUG EFFECT; ENZYMOLOGY; HOMEOSTASIS; METABOLISM; MITOCHONDRION; PANCREAS; PATHOLOGY; PROTEIN TRANSPORT; SECRETION; TIME; WISTAR RAT;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BLOOD GLUCOSE; DYSLIPIDEMIAS; FENOFIBRATE; GLUCOSE; HOMEOSTASIS; INSULIN; MALONDIALDEHYDE; MITOCHONDRIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; PANCREAS; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SODIUM GLUTAMATE; TIME FACTORS; UP-REGULATION;

EID: 80053946288     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-176     Document Type: Article

References (38)

1. Jones PS, Savory R, Barratt P, Bell AR, Gray TJ, Jenkins NA, Gilbert DJ, Copeland NG, Bell DR. Chromosomal localisation, inducibility, tissuespecific expression and strain differences in three murine peroxisome proliferator-activated receptor genes. Eur J Biochem 1995, 233:219-226. 10.1111/j.1432-1033.1995.219_1.x, 7588749.
2. Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 2000, 275:16638-16642. 10.1074/jbc.275.22.16638, 10828060.
3. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 2001, 50:411-417. 10.2337/diabetes.50.2.411, 11272155.
4. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 2001, 50:1771-1777. 10.2337/diabetes.50.8.1771, 11473037.
5. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006, 116:571-580. 10.1172/JCI27989, 1386122, 16511589.
6. Holness MJ, Smith ND, Greenwood GK, Sugden MC. Acute (24 h) activation of peroxisome-proliferator-activated receptor (PPAR) alpha reverses high-fat feeding induced insulin hypersecretion in vivo and in perifused pancreatic islets. J Endocrinol 2003, 177:197-205. 10.1677/joe.0.1770197, 12740007.
7. Roduit R, Morin J, Massé F, Segall L, Roche E, Newgard CB, Assimacopoulos-Jeannet F, Prentki M. Glucose downregulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta-cell. J Biol Chem 2000, 275:35799-35806. 10.1074/jbc.M006001200, 10967113.
8. Sugden MC, Greenwood GK, Smith ND, Holness MJ. Peroxisome proliferator-activated receptor-alpha activation during pregnancy attenuates glucose-stimulated insulin hypersecretion in vivo by increasing insulin sensitivity, without impairing pregnancy-induced increases in beta-cell glucose sensing and responsiveness. Endocrinology 2003, 144:146-153. 10.1210/en.2002-220811, 12488340.
9. Yoshikawa H, Tajiri Y, Sako Y, Hashimoto T, Umeda F, Nawata H. Effects of bezafibrate on beta-cell function of rat pancreatic islets. Eur J Pharmacol 2001, 426:201-206. 10.1016/S0014-2999(01)01204-3, 11527545.
10. Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP, Semenkovich CF. PPAR alpha suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 2002, 43:936-943.
11. Bunyan J, Murrell EA, Shah PP. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 1976, 35:25-39. 10.1079/BJN19760005, 1106764.
12. Nagata M, Susuki W, Iisuka S, Takeda S, Aburada M, Miyamoto K. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Exp Anim 2006, 55:109-115. 10.1538/expanim.55.109, 16651693.
13. Liu SN, Liu Q, Shen ZF. A preliminary study on the mechanism of impaired beta cell function in monosodium glutamate obese rat with insulin resistance. Acta Pharm Sin 2008, 43:1106-1111.
14. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46:1733-1742. 10.2337/diabetes.46.11.1733, 9356019.
15. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y. Glycation-dependent, reactive oxygen species mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 1997, 99:144-150. 10.1172/JCI119126, 507778, 9011569.
16. Malaisse WJ, Boschero AC, Kawazu S, Hutton JC. The stimulus secretion coupling of glucose-induced insulin release. XXVII. Effect of glucose on K+ fluxes in isolated islets. Pflu"gers Arch 1978, 373:237-242.
17. Pecqueur C, Alves-Guerra MC, Gelly C, Levi-Meyrueis C, Couplan E, Collins S, Ricquier D, Bouillaud F, Miroux B. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 2001, 276:8705-8712. 10.1074/jbc.M006938200, 11098051.
18. Shalwitz RA, Beth TJ, MacLeod AM, Tucker SJ, Rolison GG. Use of 2H2O to study labeling in plasma glucose and hepatic glycogen during a hyperglycemic clamp. Am J Physiol 1994, 266:433-437.
19. Serradas P, Gangnerau MN, Giroix MH, Saulnier C, Portha B. Impaired pancreatic beta cell function in the fetal GK rat. Impact of diabetic inheritance. J Clin Invest 1998, 101:899-904. 10.1172/JCI368, 508638, 9466985.
20. Lowry OH, Rosebrough NJ, Farr A, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
21. Eckert C, Landt O, Taube T, Seeger K, Beyermann B, Proba J, Henze G. Potential of Light Cycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 2000, 14:316-323. 10.1038/sj.leu.2401655, 10673751.
22. Viegas MS, Martins TC, Seco F, do Carmo A. An improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissues. Eur J Histochem 2007, 51:59-66.
23. Lalloyer F, Vandewalle B, Percevault F, Torpier G, Kerr-Conte J, Oosterveer M, Paumelle R, Fruchart JC, Kuipers F, Pattou F, Fiévet C, Staels B. Peroxisome Proliferator-Activated Receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 2006, 55:1605-1613. 10.2337/db06-0016, 16731822.
24. Jia DM, Tabaru A, Nakamura H, Fukumitsu KI, Akiyama T, Otsuki M. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes. Metabolism 2000, 49:1167-1175. 10.1053/meta.2000.8599, 11016899.
25. Yoshikawa H, Tajiri Y, Sako Y, Hashimoto T, Umeda F, Nawata H. Effects of bezafibrate on beta-cell function of rat pancreatic islets. Eur J Pharmacol 2001, 426:201-206. 10.1016/S0014-2999(01)01204-3, 11527545.
26. Krause BR, Barnett BC, Essenburg AD, Kieft KA, Auerbach BJ, Bousley R, Stanfield R, Newton RS, Bisgaier CL. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats. Atherosclerosis 1996, 127:91-101. 10.1016/S0021-9150(96)05939-4, 9006809.
27. Berthou L, Saladin R, Yaqoob P, Branellec D, Calder P, Fluchart JC, Denèfle P, Auwerx J, Staels B. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids. Eur J Biochem 1995, 232:179-187. 10.1111/j.1432-1033.1995.tb20797.x, 7556148.
28. Staels B, Van Tol A, Skretting G, Auwerx J. Lecithin: cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates. J Lipid Res 1992, 33:727-735.
29. Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, Guillouzo A, Fruchart JC, Rubin E, Denèfle P, Staels B, Branellec D. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J Clin Invest 1996, 97:2408-2416. 10.1172/JCI118687, 507325, 8647932.
30. Vu-Dac N, Schoonjans K, Laine B, Fruchart JC, Auwerx J, Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 1994, 269:31012-31018.
31. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008, 29:351-366. 2528858, 18048763.
32. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001, 105:745-755. 10.1016/S0092-8674(01)00378-6, 11440717.
33. Zhou Z, Gengaro P, Wang W, Wang XQ, Li C, Faubel S, Rivard C, Schrier RW. Role of NF-kappaB and PI 3-kinase/Akt in TNF-alpha-induced cytotoxicity in microvascular endothelial cells. Am J Physiol Renal Physiol 2008, 295:932-941.
34. Dobashi K, Araki S, Kubo K, Kawagoe R, Yamamoto Y, Shirahata A. Hydroxymethylglutaryl-CoA reductase inhibitor inhibits induction of nitric oxide synthase in 3T3-L1 preadipocytes. Life Sci 2008, 82:85-90. 10.1016/j.lfs.2007.10.013, 18036617.
35. Størling J, Binzer J, Andersson AK, Züllig RA, Tonnesen M, Lehmann R, Spinas GA, Sandler S, Billestrup N, Mandrup-Poulsen T. Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 2005, 48:2039-2050. 10.1007/s00125-005-1912-2, 16132952.
36. Konturek JW, Hengst K, Kulesza E, Gabryelewicz A, Konturek SJ, Domschke W. Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans. Gut 1997, 40:86-91. 1027013, 9155581.
37. Salehi A, Ekelund M, Lundquist I. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1. Horm Metab Res 2003, 35:48-54. 10.1055/s-2003-38391, 12669271.
38. Jimenez-Feltstrom J, Lundquist I, Salehi A. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway. Cell Tissue Res 2005, 319:221-230. 10.1007/s00441-004-1013-4, 15558323.